Suppr超能文献

病例报告:静脉注射喷他脒挽救治疗 HIV-1 感染患者的活动性慢性内脏利什曼病。

Case Report: Intravenous Pentamidine Rescue Treatment for Active Chronic Visceral Leishmaniasis in an HIV-1 Infected Patient.

机构信息

Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy.

Infectious and Tropical Diseases Unit, Careggi University Hospital, Florence, Italy.

出版信息

Am J Trop Med Hyg. 2021 Nov 15;106(2):639-642. doi: 10.4269/ajtmh.21-0600.

Abstract

The management of visceral leishmaniasis (VL) in HIV-infected patients is complex because of high mortality rates, toxic drug-related side effects, and a high risk of treatment failure and relapse. We report a case of active chronic VL in an HIV-1-infected woman presenting multiple secondary VL episodes over 7 years leading to massive splenomegaly and blood transfusion-dependent anemia despite several treatment courses and secondary prophylaxis. The patient was finally successfully treated with rescue treatment based on intravenous pentamidine. Twenty months after discontinuation of pentamidine the patient presented complete clinical and parasitological response. In patients with active chronic VL, treatment with intravenous pentamidine can be effective and should be considered as rescue treatment.

摘要

HIV 感染者内脏利什曼病(VL)的管理很复杂,因为死亡率高、药物相关毒性副作用以及治疗失败和复发的风险高。我们报告了一例 HIV-1 感染妇女的活动性慢性 VL 病例,该患者在 7 年中多次出现继发性 VL 发作,导致巨脾和依赖输血的贫血,尽管进行了多次治疗和二级预防。最终,该患者通过基于静脉注射戊烷脒的抢救治疗成功治愈。在停止注射戊烷脒后 20 个月,患者出现完全的临床和寄生虫学应答。对于活动性慢性 VL 患者,静脉注射戊烷脒治疗可能有效,应考虑作为抢救治疗。

相似文献

6
Pentamidine as secondary prophylaxis for visceral leishmaniasis in the immunocompromised host: report of four cases.
Trop Med Int Health. 2009 Sep;14(9):1064-70. doi: 10.1111/j.1365-3156.2009.02329.x. Epub 2009 Jun 22.
7
Serial use of pentamidine and miltefosine for treating Leishmania infantum-HIV coinfection.
Parasitol Int. 2016 Oct;65(5 Pt A):444-6. doi: 10.1016/j.parint.2016.06.009. Epub 2016 Jun 22.
8
Visceral leishmaniasis in HIV-1-infected individuals: a common opportunistic infection in Spain?
AIDS. 1992 Dec;6(12):1499-503. doi: 10.1097/00002030-199212000-00013.

本文引用的文献

3
Visceral leishmaniosis in immunocompromised host: an update and literature review.
J Chemother. 2017 Oct;29(5):261-266. doi: 10.1080/1120009X.2017.1323150. Epub 2017 May 10.
5
Antileishmanial Mechanism of Diamidines Involves Targeting Kinetoplasts.
Antimicrob Agents Chemother. 2016 Oct 21;60(11):6828-6836. doi: 10.1128/AAC.01129-16. Print 2016 Nov.
8
Neurological manifestations of human leishmaniasis.
Handb Clin Neurol. 2013;114:193-8. doi: 10.1016/B978-0-444-53490-3.00013-3.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验